Article
BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
The oncologist - 1 Jan 2013
Lindor Noralane M, Goldgar David E, Tavtigian Sean V, Plon Sharon E, Couch Fergus J
Abstract excerpt
INTRODUCTION: DNA variants of uncertain significance (VUS) are common outcomes of clinical genetic testing for susceptibility to cancer. A statistically rigorous model that provides a pathogenicity score for each variant has been developed to aid in the clinical management of patients undergoing genetic testing. METHODS: The information in this article is derived from multiple publications on VUS in BRCA genes,...
Topics
- BRCA1 Protein
- BRCA2 Protein
- Breast Neoplasms
- Female
- Genetic Predisposition to Disease
- Genetic Testing
- Genetic Variation
- Humans
- Likelihood Functions
- Middle Aged
- Models, Statistical
